About Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene
Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene is a rare disease catalogued by Orphanet (ORPHA:715143). It is associated with the HBB, HBA2, HBA1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene trials.
Search ClinicalTrials.gov for "Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene" or filter by Orphanet code ORPHA:715143 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Heterozygous beta-thalassemia intermedia with supernumerary alpha-globin gene. Updated daily.